In a smaller sub-analysis trial of 30 kids, the additional dose led to a thirty-six fold increase in antibodies against the omicron variant, according to a statement from Pfizer.But for parents like Gorman, the waiting game continues for children under the age of 5.
Pfizer has been testing smaller doses for children under 5 but had to add a third shot to its study when two didn’t prove strong enough. Those results were expected by early April, though no announcement has been made so far.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.